Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
Ki67免疫组化表达水平≥70%、肿瘤体积≥7.5 cm、脑膜淋巴瘤病以及4个疗程后PET ΔSUVmax<71%作为预测弥漫性大B细胞淋巴瘤无进展生存期和总生存期的实用评分系统的一部分
期刊:Frontiers in Nuclear Medicine
影响因子:1.4
doi:10.3389/fnume.2022.829138
Rebière, Vincent; Maajem, Meriem; Le Calloch, Ronan; Raj, Leela; Le Bris, Anne-Sophie; Malou, Mohamed; Salmon, François; Quintin-Roué, Isabelle; Tempescul, Adrian; Bourhis, David; Samaison, Laura; Saad, Hussam; Salaun, Pierre-Yves; Berthou, Christian; Ianotto, Jean-Christophe; Abgral, Ronan; Eveillard, Jean-Richard
B细胞
肿瘤
IHC
肿瘤免疫
淋巴瘤
神经科学
细胞生物学
免疫/内分泌
